Loading...
•
Dec 31, 2021
Globus Medical Q4 2021 Earnings Report
Globus Medical reported an increase in worldwide net sales and a decrease in GAAP net income for the fourth quarter of 2021.
Key Takeaways
Globus Medical's Q4 2021 results showed a 7.1% increase in worldwide net sales compared to Q4 2020, reaching $250.0 million. GAAP net income decreased by 71.5% to $15.1 million, while non-GAAP diluted EPS was $0.49. The company's Enabling Technology momentum was driven by the clinical superiority of ExcelsiusGPS®, with a record $25 million in revenue.
Worldwide net sales increased by 7.1% to $250.0 million compared to Q4 2020.
GAAP net income for the quarter was $15.1 million.
GAAP diluted EPS was $0.14, and non-GAAP diluted EPS was $0.49.
Non-GAAP adjusted EBITDA was $85.2 million, representing 34.1% of net sales.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The Company announced full year 2022 guidance with expected net sales of $1.025 billion and non-GAAP diluted earnings per share of $2.10.
Positive Outlook
- Expected net sales of $1.025 billion for full year 2022.
- Non-GAAP diluted earnings per share of $2.10 for full year 2022.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...